Intratumoural injection of synthetic cyclic dinucleotides (CDNs) in mice has been demonstrated to rapidly induce IFN-β production in intra-tumour immune cells and create anti-tumour-specific CD3+CD8+ T cells that limit tumour development [37,38]. This evidence concerns the gene CD8A and neoplasm.